LAVAL, QC, April 7 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the
Company") (TSX: BSY), a biotechnology company developing novel products in
regenerative medicine, today announced that it has achieved international
certification under the stringent and globally recognized ISO 13485:2003
Medical Devices Quality Management System for its site located in Laval,
Quebec. BioSyntech continues to maintain its ISO 9001:2000 certificate.
